Epizyme, inc. (EPZM)
Income statement / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11
Revenue:
Total revenue

23,800

21,700

10,000

8,007

2,560

41,411

68,482

45,222

6,944

Operating expenses:
Research and development

132,639

105,833

109,661

91,461

111,209

75,595

57,567

38,482

22,911

General and administrative

68,303

43,972

37,181

28,372

23,900

20,866

14,042

7,508

5,000

Total operating expenses

200,942

149,805

146,842

119,833

135,109

96,461

71,609

45,990

27,911

Operating loss

-177,142

-128,105

-136,842

-111,826

-132,549

-55,050

-3,127

-768

-20,967

Other income, net:
Interest income, net

7,110

4,557

2,165

1,531

94

95

74

145

33

Other (expense), net

-13

-25

32

83

79

59

-81

-78

-23

Non-cash interest expense related to sale of future royalties

192

-

-

-

-

-

-

-

-

Other income, net

6,905

4,532

2,197

1,614

173

154

-7

67

10

Loss before income taxes

-170,237

-123,573

-134,645

-110,212

-132,376

-54,896

-3,134

-701

-20,957

Income tax (provision) benefit

58

57

-336

-

0

109

349

1

-

Net loss

-170,295

-123,630

-134,309

-110,212

-132,376

-55,005

-3,483

-702

-20,957

Other comprehensive income (loss):
Unrealized (loss) gain on available-for-sale securities

73

-5

57

-106

-

-

-

-

-

Comprehensive loss

-170,222

-123,635

-134,252

-110,318

-132,376

-55,005

-3,483

-702

-20,957

Reconciliation of net loss to net loss attributable to common stockholders:
Net loss

-170,295

-123,630

-134,309

-

-

-

-

-

-

Accretion of convertible preferred stock

2,940

-

-

-

-

-

-

-

-

Less: accretion of redeemable convertible preferred stock to redemption value

-

-

-

-

-

-

264

486

45

Net loss attributable to common stockholders

-173,235

-123,630

-134,309

-

-

-

-3,747

-1,188

-21,002

Net loss per share attributable to common stockholders:
Basic

-1.93

-1.72

-2.18

-1.93

-3.32

-1.67

-0.22

-0.72

-14.65

Diluted

-1.93

-1.72

-2.18

-1.93

-3.32

-1.67

-0.22

-0.72

-14.65

Weighted-average common shares outstanding used in net loss per share attributable to common stockholders:
Basic

89,891

71,864

61,471

57,126

39,839

33,027

17,049

1,645

1,434

Diluted

89,891

71,864

61,471

57,126

39,839

33,027

17,049

1,645

1,434